TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1736868

Group type: EXPERIMENTAL
Intervention: Minimal essential medium at 31 degrees C
Number of subjects: 28

Group type: COMPARATOR
Intervention: McCarey-Kaufman medium at 4 degrees C
Number of subjects: 28
Study: 6430337

Group type: EXPERIMENTAL
Intervention: DDAVP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naloxone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline
Number of subjects: 0
Study: 31448533

Group type: EXPERIMENTAL
Intervention: Lactulose (Gp-L)
Number of subjects: 98

Group type: COMPARATOR
Intervention: No therapy (Gp-NL)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Lactulose responders
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: MHE patients
Number of subjects: 98
Study: 30327358

Group type: EXPERIMENTAL
Intervention: Euglycemic hyperinsulinemia
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Acute hypoglycemia
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Hypoglycemic clamp
Number of subjects: 23
Study: 29231522

Group type: EXPERIMENTAL
Intervention: Combined therapy of moxibustion along the governor vessel and the conception vessel with salazosulfapyridine (SASP)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Routine moxibustion therapy
Number of subjects: 62
Study: 25371536

Group type: EXPERIMENTAL
Intervention: BMS postdilated with SeQuent Please DEB
Number of subjects: 90

Group type: COMPARATOR
Intervention: XIENCE V DES
Number of subjects: 90
Study: 23210421

Group type: EXPERIMENTAL
Intervention: 500 ppm fluoride mouthwash
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 225 ppm fluoride mouthwash
Number of subjects: 30

Group type: COMPARATOR
Intervention: No rinse
Number of subjects: 30
Study: 20179727

Group type: EXPERIMENTAL
Intervention: Phytosphingosine (PS) 500 mg twice daily
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 12
Study: 18392052

Group type: EXPERIMENTAL
Intervention: Catch-up vaccination
Number of subjects: 24510
Study: 16382257

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 11638

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 11638
Study: 12487780

Group type: EXPERIMENTAL
Intervention: F(ab')(2) FRaMon 0.2 mg/kg
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: F(ab')(2) FRaMon 0.25 mg/kg
Number of subjects: 58

Group type: COMPARATOR
Intervention: abciximab
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: F(ab')(2) FRaMon
Number of subjects: 58
Study: 9437382

Group type: EXPERIMENTAL
Intervention: Triple-lumen catheters coated with chlorhexidine and silver sulfadiazine (CSS)
Number of subjects: 308

Group type: COMPARATOR
Intervention: Uncoated triple-lumen catheters
Number of subjects: 308
Study: 7865980

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 5.7, 11.4, and 17.1 pmol kg‐1 min‐1 CDD/ANP‐99‐126
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of CDD/ANP‐99‐126
Number of subjects: 0
Study: 2673438

Group type: EXPERIMENTAL
Intervention: Monthly three day course with adriamycin (ADM), cyclophosphamide (CPM), vindesine (VDS) and 5 fluoro‐uracil (5 FU)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Fractionated schedule with 4 injections of ADM, CPM, VDS and continuous infusion of 5 FU over 10 days
Number of subjects: 94
Study: 338104

Group type: EXPERIMENTAL
Intervention: Oestrogen (piperazine oestrone sulphate)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 30841501

Group type: EXPERIMENTAL
Intervention: Receiving abortions (repeat abortions)
Number of subjects: 2370

Group type: EXPERIMENTAL
Intervention: Non-use of contraception
Number of subjects: 2370

Group type: EXPERIMENTAL
Intervention: Having children
Number of subjects: 2370

Group type: EXPERIMENTAL
Intervention: Residing in a middle-developed region
Number of subjects: 2370

Group type: EXPERIMENTAL
Intervention: Residing in a relatively poor region
Number of subjects: 2370

Group type: EXPERIMENTAL
Intervention: Using contraception (condom use)
Number of subjects: 2370

Group type: EXPERIMENTAL
Intervention: Occupation as a student
Number of subjects: 2370
Study: 29027108

Group type: EXPERIMENTAL
Intervention: FLT3‐ITD mutation
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: NPM1 mutation
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: NPM1 mutations in absence of FLT3‐ITD
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: FLT3‐ITD in absence of NPM1 mutations
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Overall survival (OS)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Event-free survival
Number of subjects: 103

Group type: COMPARATOR
Intervention: Comparison of OS among AYAs, children, and older adults
Number of subjects: 103
Study: 26624965

Group type: EXPERIMENTAL
Intervention: Jumping Interval Training (JIT)
Number of subjects: 18
Study: 24795251

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg
Number of subjects: 664

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg
Number of subjects: 664

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 664
Study: 22392354

Group type: EXPERIMENTAL
Intervention: Desarda technique (D)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Lichtenstein technique (L)
Number of subjects: 208
Study: 19672152

Group type: EXPERIMENTAL
Intervention: gemcitabine plus LY293111 (LY) 600 mg twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: gemcitabine plus placebo
Number of subjects: 0
Study: 17502466

Group type: EXPERIMENTAL
Intervention: Rotigotine transdermal system (2, 4, or 6 mg during 24 hours for 24 weeks)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 277

Group type: EXPERIMENTAL
Intervention: Rotigotine transdermal system
Number of subjects: 277
Study: 15031343

Group type: EXPERIMENTAL
Intervention: Alfacalcidol treatment
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 36
Study: 12153335

Group type: COMPARATOR
Intervention: Ziprasidone 80 or 160 mg/day
Number of subjects: 300

Group type: COMPARATOR
Intervention: Ziprasidone 160 mg/day
Number of subjects: 300

Group type: COMPARATOR
Intervention: Ziprasidone 40 to 160 mg/day
Number of subjects: 300

Group type: COMPARATOR
Intervention: Ziprasidone
Number of subjects: 300

Group type: COMPARATOR
Intervention: Intramuscular ziprasidone
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Long-term oral ziprasidone treatment
Number of subjects: 300
Study: 9222908

Group type: EXPERIMENTAL
Intervention: Ulnar L incision
Number of subjects: 47

Group type: COMPARATOR
Intervention: Standard incision
Number of subjects: 47
Study: 7702784

Group type: EXPERIMENTAL
Intervention: ondansetron plus metoclopramide
Number of subjects: 66

Group type: COMPARATOR
Intervention: ondansetron alone
Number of subjects: 66
Study: 3665218

Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (ISMN) 40 mg
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate (ISDN) 40 mg
Number of subjects: 20
Study: 30357437

Group type: EXPERIMENTAL
Intervention: Ketamine (subanesthetic dose, target plasma level 100 ng/ml)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 28236583

Group type: COMPARATOR
Intervention: BEACOPPescalated
Number of subjects: 440

Group type: EXPERIMENTAL
Intervention: R-BEACOPPescalated
Number of subjects: 440
Study: 26302337

Group type: EXPERIMENTAL
Intervention: Buprenorphine/naloxone (BUP/NLX) and counseling for 12 weeks
Number of subjects: 149
Study: 23674608

Group type: EXPERIMENTAL
Intervention: 10 mg rifampicin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 20 mg rifampicin
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 100 mg rifampicin
Number of subjects: 24
Study: 19767711

Group type: EXPERIMENTAL
Intervention: Psychiatric drug therapy in addition to topical corticosteroids
Number of subjects: 46

Group type: COMPARATOR
Intervention: Topical corticosteroids only (Control)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Psychiatric drug therapy
Number of subjects: 46
Study: 18355656

Group type: EXPERIMENTAL
Intervention: Triple antiplatelet therapy (aspirin, clopidogrel, and cilostazol)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Dual antiplatelet therapy (aspirin and clopidogrel)
Number of subjects: 400
Study: 16553140

Group type: EXPERIMENTAL
Intervention: Tai chi chuan (TCC) 3 times/wk for 12 weeks
Number of subjects: 21

Group type: COMPARATOR
Intervention: Psychosocial therapy (PST; physical activity control) 3 times/wk for 12 weeks
Number of subjects: 21
Study: 12692051

Group type: EXPERIMENTAL
Intervention: Tegaserod 6 mg twice daily (n=259)
Number of subjects: 520

Group type: COMPARATOR
Intervention: Placebo (n=261)
Number of subjects: 520
Study: 11083356

Group type: EXPERIMENTAL
Intervention: Low intensity laser therapy (1.06-microm continuous wave laser emitting 204 mW/cm2 for 60 seconds at 7 points along the symptomatic forearm, 3 times weekly for 4 weeks)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (inactive laser treatment)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Low intensity laser therapy
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study: 8810592

Group type: COMPARATOR
Intervention: Whole-blood PMN and alveolar PMN obtained by bronchoalveolar lavage (BAL) in ARDS patients
Number of subjects: 29

Group type: COMPARATOR
Intervention: Ex vivo stimulation of alveolar PMN by a bacterial peptide
Number of subjects: 29

Group type: COMPARATOR
Intervention: Degree of PMN activation
Number of subjects: 29
Study: 7930301

Group type: EXPERIMENTAL
Intervention: Cromolyn sodium (10 mg)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (4 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (two puffs)
Number of subjects: 17
Study: 3687822

Group type: EXPERIMENTAL
Intervention: Low-fat diet (15-20% energy from fat)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Medium-fat diet (30-35% energy from fat)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High-fat diet (45-50% energy from fat)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: All diets
Number of subjects: 24
Study: 30013701

Group type: EXPERIMENTAL
Intervention: Seated position
Number of subjects: 42

Group type: COMPARATOR
Intervention: Standing position
Number of subjects: 42
Study: 28915904

Group type: EXPERIMENTAL
Intervention: manualised Psychoanalytic Child Psychotherapy (mPCP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment as Usual (TaU)
Number of subjects: 60
Study: 24447183

Group type: EXPERIMENTAL
Intervention: HTNV DNA vaccine (2.0 mg total dose, 1 mL saline, administered on days 0, 28, and 56)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: PUUV DNA vaccine (2.0 mg total dose, 1 mL saline, administered on days 0, 28, and 56)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Combined HTNV and PUUV DNA vaccines (1.0 mg each, 2.0 mg total dose, 1 mL saline, administered on days 0, 28, and 56)
Number of subjects: 27
Study: 23169276

Group type: EXPERIMENTAL
Intervention: Health advocate nurse-led intervention (usual and customary plus additional services from Cigna)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual and customary services (control group)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Health advocate nurse-led intervention
Number of subjects: 0
Study: 19762206

Group type: EXPERIMENTAL
Intervention: Supervised Exercise Program (SEP)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Percutaneous Transluminal Angioplasty (PTA)
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Combined Therapy (PTA + SEP)
Number of subjects: 178

Group type: COMPARATOR
Intervention: PTA + SEP
Number of subjects: 178
Study: 17693146

Group type: EXPERIMENTAL
Intervention: Superficial temporal artery (STA) and facial artery (FA) pedicle technique
Number of subjects: 6

Group type: COMPARATOR
Intervention: External carotid artery (ECA) pedicle technique
Number of subjects: 6
Study: 15765240

Group type: EXPERIMENTAL
Intervention: Hypergravity with ergometric exercise (30 min at +1.2 Gz acceleration, 60 W for 4 subjects, 40 W for 2 subjects)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (no hypergravity exercise)
Number of subjects: 12
Study: 12144577

Group type: EXPERIMENTAL
Intervention: BTF (Bismuth, Tetracycline, Furazolidone)
Number of subjects: 70

Group type: COMPARATOR
Intervention: OBTM (Omeprazole, Bismuth, Tetracycline, Metronidazole)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: BTF
Number of subjects: 70

Group type: COMPARATOR
Intervention: OBTM
Number of subjects: 70
Study: 9850002

Group type: EXPERIMENTAL
Intervention: Prompt tympanostomy tube placement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed tympanostomy tube placement
Number of subjects: 0
Study: 7755003

Group type: EXPERIMENTAL
Intervention: Random-effects regression model for analysis of clustered data
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ordinary regression analysis of clustered data
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cluster-level analysis
Number of subjects: 0
Study: 3133327

Group type: EXPERIMENTAL
Intervention: Radiation and adjuvant estrogen (diethylstilbestrol)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Radiation only
Number of subjects: 78
Study: 31583533

Group type: EXPERIMENTAL
Intervention: Azithromycin + Lactulose
Number of subjects: 87

Group type: COMPARATOR
Intervention: Azithromycin
Number of subjects: 87
Study: 29332240

Group type: EXPERIMENTAL
Intervention: Preperitoneal closed-system suction drainage
Number of subjects: 90

Group type: COMPARATOR
Intervention: No-drain
Number of subjects: 90
Study: 25536639

Group type: EXPERIMENTAL
Intervention: TVR-standard group (2,250 mg TVR for 12 weeks plus reduced ribavirin dose)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: TVR-reduced group (1,500 mg TVR plus standard ribavirin dose)
Number of subjects: 62

Group type: COMPARATOR
Intervention: TVR-standard group
Number of subjects: 62

Group type: COMPARATOR
Intervention: TVR-reduced group
Number of subjects: 62

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 62
Study: 23190874

Group type: EXPERIMENTAL
Intervention: Fish consumption
Number of subjects: 29

Group type: COMPARATOR
Intervention: Fish oil supplements
Number of subjects: 29
Study: 21481003

Group type: EXPERIMENTAL
Intervention: New gustatory stimulant of salivary secretion (GSSS) containing weaker malic acid, fluoride, and xylitol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Traditional citric acid-based gustatory stimulant of salivary secretion (GSSS)
Number of subjects: 80
Study: 18421507

Group type: EXPERIMENTAL
Intervention: Stop orders for indwelling urinary catheters
Number of subjects: 692

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 692
Study: 16931252

Group type: EXPERIMENTAL
Intervention: Paired opposite clear corneal incisions (OCCIs)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Single clear corneal incisions (CCIs)
Number of subjects: 40
Study: 12673261

Group type: EXPERIMENTAL
Intervention: Blue LED phototherapy
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Blue-green LED phototherapy
Number of subjects: 114

Group type: COMPARATOR
Intervention: Conventional phototherapy
Number of subjects: 114
Study: 10714690

Group type: EXPERIMENTAL
Intervention: Combination cyclopentolate 0.2% and phenylephrine 1% eyedrops
Number of subjects: 28

Group type: COMPARATOR
Intervention: Triple instillation of tropicamide 0.5% and phenylephrine 2.5%
Number of subjects: 28
Study: 9424323

Group type: EXPERIMENTAL
Intervention: MCAF/MCP1 concentrations in BALF from patients with chronic bronchitis
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (14 patients aged 30.5 +/- 3.4 years)
Number of subjects: 32
Study: 1576488

Group type: EXPERIMENTAL
Intervention: 100 IU of salmon calcitonin and 500 mg of elemental calcium for 10 consecutive days each month
Number of subjects: 32

Group type: COMPARATOR
Intervention: 500 mg of elemental calcium only for 10 consecutive days each month
Number of subjects: 32
Study: 3907580

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 0
Study: 30982716

Group type: EXPERIMENTAL
Intervention: Pain medication (paracetamol, opioids, or both)
Number of subjects: 407

Group type: COMPARATOR
Intervention: No pain medication
Number of subjects: 407

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 407
Study: 30202939

Group type: EXPERIMENTAL
Intervention: Brief manualised group intervention on the interrelation of AUD and MD or PTSD
Number of subjects: 171

Group type: COMPARATOR
Intervention: Cognitive training session (control group)
Number of subjects: 171
Study: 27041272

Group type: EXPERIMENTAL
Intervention: Subtenon block with mixture of 4 mL of 2% lidocaine and 0.5% bupivacaine (50:50)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Subtenon injection of saline
Number of subjects: 80
Study: 23996878

Group type: EXPERIMENTAL
Intervention: Postoperative intensity‐modulated radiation therapy (IMRT)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Conventional radiotherapy (RT)
Number of subjects: 88
Study: 22499521

Group type: EXPERIMENTAL
Intervention: 10 mg metoclopramide intramuscular injection after swallowing the capsule
Number of subjects: 116

Group type: COMPARATOR
Intervention: No metoclopramide administered (Control)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: 10 mg metoclopramide intramuscular injection
Number of subjects: 116
Study: 20727717

Group type: EXPERIMENTAL
Intervention: Intensive community care
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Omega-3 polyunsaturated fatty acids (Omega-3 PUFAs) supplementation
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Focused treatment groups (various interventions)
Number of subjects: 337

Group type: COMPARATOR
Intervention: Control UHR groups (no treatment or treatment as usual)
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Any focused treatment
Number of subjects: 337
Study: 19227196

Group type: EXPERIMENTAL
Intervention: Cuff compression (250 mmHg) for 10 min
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cuff compression (250 mmHg) for 26 min
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cuff compression (250 mmHg) for both 10 min and 26 min
Number of subjects: 10
Study: 16199148

Group type: EXPERIMENTAL
Intervention: Formoterol 9 microg bid plus terbutaline 0.5 mg as needed (FORM bid)
Number of subjects: 657

Group type: EXPERIMENTAL
Intervention: Formoterol 9 microg bid plus formoterol 4.5 microg as needed (FORM bid+prn)
Number of subjects: 657

Group type: COMPARATOR
Intervention: Placebo bid plus terbutaline 0.5 mg as needed (placebo)
Number of subjects: 657
Study: 11898986

Group type: EXPERIMENTAL
Intervention: Free riding with justification (justified by low ability)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Free riding
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: No free riding
Number of subjects: 97
Study: 10626340

Group type: EXPERIMENTAL
Intervention: Conventional treatment + complex of amino acids (100 mg 3 times a day sublingually)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Adjuvant preductal (20 mg 3 times a day per os for 20 days)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional antianginal therapy (nitrates, beta-adrenoblockers, calcium antagonists, diuretics, ACI inhibitors, cardiac glycosides, and aspirin)
Number of subjects: 60
Study: 8520738

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (MPSS) at 1 gm intravenously 5 min before CPB (Group S)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No intervention (Group N)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group of 10 patients undergoing repair of infrarenal aortic aneurysms
Number of subjects: 20
Study: 1836810

Group type: EXPERIMENTAL
Intervention: Long-acting GnRH-a (Decapeptyl) and hMG
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Short-acting GnRH-a (Buserelin) and hMG
Number of subjects: 175

Group type: COMPARATOR
Intervention: hMG only
Number of subjects: 175
Study: 7020141

Group type: EXPERIMENTAL
Intervention: Cefazolin intravenously, 1 gm 2 hours prior to surgery, at induction of anesthesia, and then 0.5 gm every 6 hours for 48 hours
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo of 5% dextrose at identical intervals
Number of subjects: 53
Study: 30160635

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Interval Training (MIIT)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control
Number of subjects: 82
Study: 28935269

Group type: EXPERIMENTAL
Intervention: ω3 supplementation (962mg/d for children and 1155mg/d for adolescents)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: ω3 supplementation
Number of subjects: 68
Study: 26292674

Group type: EXPERIMENTAL
Intervention: HypoAware intervention (three group sessions and two online modules)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: HypoAware intervention
Number of subjects: 154
Study: 23383726

Group type: EXPERIMENTAL
Intervention: Group counseling intervention (problem-solving therapy approach)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard of care (control group)
Number of subjects: 100
Study: 21062674

Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous insulin infusion (CSII)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Multiple daily injections of insulin (MDI)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring systems (CGMS)
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Both CSII and MDI
Number of subjects: 107
Study: 19167731

Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy (60 to 64 Gy)
Number of subjects: 431

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 431
Study: 17087947

Group type: EXPERIMENTAL
Intervention: 25 mg rofecoxib
Number of subjects: 2587

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2587
Study: 15598478

Group type: EXPERIMENTAL
Intervention: Fixed combination latanoprost 0.005% + timolol maleate 0.5% QD
Number of subjects: 350

Group type: COMPARATOR
Intervention: Latanoprost 0.005% QD
Number of subjects: 350
Study: 11511562

Group type: EXPERIMENTAL
Intervention: ABT-229 1.25 mg
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: ABT-229 2.5 mg
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: ABT-229 5 mg
Number of subjects: 270

Group type: EXPERIMENTAL
Intervention: ABT-229 10 mg
Number of subjects: 270

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study: 9250116

Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (20 mg/d)
Number of subjects: 491